|
|
 Pfizer Selects ChemAxon’s Markush Platform
|
ChemAxon has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer’s global R&D facilities.
“Markush structure search and enumeration is becoming of critical importance for structure IP and patent development.” said Alex Drijver, CEO of ChemAxon. “It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront.”back to top » |
Related Articles
Other SelectScience members who looked at this article were also interested in:
|
|
|
|
 |
|
More Options
|
|
|
clinical diagnostics
